Clinical Trial Update: Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of mirtazapine on anxiety symptoms in Parkinson disease patients. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Parkinson Disease

Drugs mentioned

• mirtazapine (mirtazapine)

Snippet

Sponsor: Leila Dargahi. PharmD PhD | Conditions: Parkinson Disease, Anxiety | Phase 2 | Status: RECRUITING